Liraglutide and sixestate - drugs used for the treatment of diabetes of the second type. Active substance stimulates the synthesis of insulin by beta cells and reduces blood sugar levels, writes The Telegraph.
Scientists from the University of Lancaster and University of Ulster proved, these same drugs can be used in Alzheimer's disease. Still managed to conduct a series of experiments with laboratory mice. A daily intake of drugs reduced the level of amyloid in the brain of animals and improve their memory.
Increasing the concentration of amyloid deposits is one of the reasons for the development of Alzheimer's disease. Drugs, Liraglutide and sixestate can become the first wave therapy, aimed not at the symptoms of the disease, and the mechanisms of its development.
A huge role is played by insulin. In addition to participation in metabolic processes, it protects the brain and restores the damaged nerve cells.
Now comes the stage of clinical trials liraglutide on patients. The results of the study will receive only next year. If all goes well, the world will get a new tool for the treatment of Alzheimer's disease in 5-10 years.